Antiviral drugs available for the prevention and treatment of influenza include neuraminidase inhibitors (e.g., oseltamivir and zanamivir) and amantadates (e.g., amantadine and rimantadine).

Antiviral drugs such as neuraminidase inhibitors (oseltamivir ... for the clinical management of severe illness caused by influenza in 2022, which conditionally recommended the use of oseltamivir.

Influenza is a viral respiratory disease that affects millions annually, with severe complications that can be fatal. Antiviral medications such as neuraminidase inhibitors, like oseltamivir ...

Between the 2017-2018 and 2023-2024 influenza seasons, the use of antiviral therapy in pediatric patients with influenza declined in both inpatient and outpatient settings.

Recent research has provided valuable insights into the susceptibility of influenza viruses to antiviral drugs, particularly neuraminidase inhibitors (NAIs) and the newer polymerase acidic (PA ...

The plan lists six anti-influenza drugs available in China, including oseltamivir, peramivir and zanamivir. It adds ...

And although neuraminidase inhibitors are effective against ... DAS181 has been shown to have potent antiviral activity against all forms of influenza, including pandemic strains such as H1N1 ...

Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

Antiviral drugs available for the prevention and treatment of influenza include neuraminidase inhibitors (e.g., oseltamivir and zanamivir) and amantadates (e.g., amantadine and rimantadine).